AOD-9604 research guide

AOD-9604 in Helpsen — Fat Loss Peptide Research Guide

AOD-9604 research guide for Helpsen. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.

Skip to Sourcing Guide Order AOD-9604 →

Research-Grade AOD-9604 for Helpsen Investigators

For anyone in Helpsen searching for AOD-9604, the first thing to know is that this compound moves through online research channels. The benefit of this online-only market is that serious vendors are judged entirely by their analytical documentation, giving researchers better verification tools than any physical store could provide. What genuinely separates top AOD-9604 vendors is full COA coverage: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for contamination assurance. This guide guides Helpsen researchers through that evaluation process and explains how to verify AOD-9604 vendor quality step by step.

Understanding AOD-9604 — Biology & Evidence

CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: AOD-9604 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Helpsen comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.

AOD-9604 Purchasing Guide

Before assessing any particular supplier, establish a quality benchmark — so you can tell whether a COA is complete and credible. Mass spectrometry in the COA establishes that the main HPLC peak is actually AOD-9604 and not a different peptide of similar polarity — HPLC purity alone does not confirm what the compound actually is. Community reputation in research forums is a valuable complement to COA verification — vendors with multi-year positive track records have built their reputation on real product performance. Price is an unreliable primary filter for AOD-9604 quality — research-grade synthesis and testing has unavoidable expenses that low-priced vendors are not absorbing, so the lowest-priced options almost always involve trade-offs.

Order AOD-9604 — ships to Helpsen
COA-verified · International tracking · Research grade
Order Now →

AOD-9604 Research Safety Guide

Research compound status for AOD-9604 means safety data comes from animal studies, in-vitro work, and limited human observations — rather than the controlled trials that generate pharmaceutical safety profiles. Storage requirements for AOD-9604: lyophilised powder at freezer temperature, reconstituted solution stored refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with sterile bacteriostatic water. Endotoxin testing in the AOD-9604 COA is not optional — gram-negative bacterial endotoxins can trigger dangerous immune responses at trace quantities, and no discount compensates for this missing data. For any individual considering AOD-9604 outside a formal research context: speak with a healthcare professional — this compound is not approved for human use and its safety characterisation does not match that of regulated drugs.

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

Order AOD-9604 today
COA-verified · International shipping available
Order Now →